SCHEMBL9998672

SCHEMBL9998672

CCCCCCCC(CC)c1cccc(C(=O)O)c1C

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
CYSLTR2 Q9NS75 1/20 0.44
CYSLTR1 Q9Y271 1/20 0.44
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43
SLC37A4 O43826 1/20 0.42
TSHR P16473 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
NR1I2 O75469 1/20 0.39
PTPN11 Q06124 1/20 0.38
PLK1 P53350 1/20 0.38
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30438055 1.00 ALDH1A1 (0.48) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL671032 0.87 ALDH1A1 (0.55) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL7942880 0.86 SLC37A4 (0.53) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL7944631 0.86 SLC37A4 (0.53) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL7942873 0.86 SLC37A4 (0.53) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL14352829 0.86 ALDH1A1 (0.41) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL433915 0.85 ALDH1A1 (0.52) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL1134750 0.84 SLC37A4 (0.54) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL342806 0.84 ALDH1A1 (0.46) ALDH1A1CYSLTR2CYSLTR1PRSS1PRSS2
SCHEMBL8147783 0.83 ALDH1A1 (0.50) ALDH1A1PRSS1PRSS2PRSS3SLC37A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582701-B1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE ALTOS THERAPEUTICS LLC (US) 2016-11-02 EP disclosed
EP-2582701-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2013-04-24 EP disclosed
WO-2011160084-A1 D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE Altos Therapeutics, LLC (US) 2011-12-22 WO disclosed